Susquehanna International Group’s ImmuCell ICCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,501
Closed -$64.7K 13137
2025
Q1
$64.7K Buy
13,501
+1,897
+16% +$9.74K ﹤0.01% 11774
2024
Q4
$59.8K Buy
+11,604
New +$46.2K ﹤0.01% 11604
2024
Q3
Sell
-20,844
Closed -$101K 12441
2024
Q2
$101K Sell
20,844
-4,369
-17% -$21K ﹤0.01% 11025
2024
Q1
$134K Sell
25,213
-8,507
-25% -$43.8K ﹤0.01% 11004
2023
Q4
$170K Buy
33,720
+16,164
+92% +$78.9K ﹤0.01% 10842
2023
Q3
$90.6K Buy
17,556
+434
+3% +$2.2K ﹤0.01% 11000
2023
Q2
$87.3K Buy
+17,122
New +$87.6K ﹤0.01% 11048
2019
Q1
Sell
-16,457
Closed -$116K 9289
2018
Q4
$116K Buy
16,457
+3,270
+25% +$25.3K ﹤0.01% 8147
2018
Q3
$110K Buy
+13,187
New +$94.9K ﹤0.01% 8567
2018
Q1
Sell
-16,600
Closed -$146K 9691
2017
Q4
$146K Buy
+16,600
New +$136K ﹤0.01% 8502

Other funds holding ICCC

Susquehanna International Group's ICCC Position: Q2 2025 in Review

Susquehanna International Group sold out of ImmuCell (ICCC) in Q2 2025, closing a stake of 13,501 shares — an estimated $64.7K sold.

Susquehanna International Group first reported a position in ICCC in Q4 2017 and held it in 10 quarters. The position peaked at $170K in Q4 2023. 25 funds tracked by Wall St. Rank hold ICCC as of Q2 2025.

  • Susquehanna International Group reported no remaining ImmuCell position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 13,501 ImmuCell shares in Q2 2025, an estimated $64.7K.
  • Susquehanna International Group first reported a position in ImmuCell in Q4 2017 and held it in 10 quarters.
  • Susquehanna International Group's ImmuCell position peaked at $170K in Q4 2023.
  • 25 funds tracked by Wall St. Rank held ImmuCell as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.